PUNE, INDIA and JUPITER, FL / ACCESSWIRE, May 9, 2019 - (ACN Newswire) - Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines,...